Third degree AV block surgery: Difference between revisions

Jump to navigation Jump to search
Line 137: Line 137:
=== '''Leadless systems''' ===
=== '''Leadless systems''' ===
In response to the limitations of existing pacings systems, leadless systems are developed. Leadless systems consist of a self-contained system that includes both the pulse generator and the electrode within a single unit that is placed into the right ventricle via a transvenous approach. Leadless cardiac pacing system was approved in April 2016 in the United States<ref><nowiki>http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm494390.htm</nowiki> </ref><br />
In response to the limitations of existing pacings systems, leadless systems are developed. Leadless systems consist of a self-contained system that includes both the pulse generator and the electrode within a single unit that is placed into the right ventricle via a transvenous approach. Leadless cardiac pacing system was approved in April 2016 in the United States<ref><nowiki>http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm494390.htm</nowiki> </ref><br />
==INDICATIONS FOR PERMANENT PACEMAKERS==
The American College of Cardiology, the American Heart Association, and the Heart Rhythm Society (ACC/AHA/HRS)  published guidelines for implantation of cardiac pacemakers<ref>Kusumoto FM, Schoenfeld MH, Barrett C, et al. [https://pubmed.ncbi.nlm.nih.gov/30412709/?from_single_result=30412709&show_create_notification_links=False 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society] [published correction appears in J Am Coll Cardiol. 2019 Aug 20;74(7):1016-1018]. ''J Am Coll Cardiol''. 2019;74(7):e51‐e156. doi:10.1016/j.jacc.2018.10.044</ref>. Some of these indications are certain, while others require considerable expertise and judgment.Similar and concordant guidelines have also been established by the European Society of Cardiology <ref>Brignole M, Auricchio A, Baron-Esquivias G, et al. [https://academic.oup.com/eurheartj/article/34/29/2281/401445 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)]. ''Eur Heart J''. 2013;34(29):2281‐2329. doi:10.1093/eurheartj/eht150</ref>.
The ACC/AHA/HRS guidelines divided these guidelines for pacemaker implantation into three specific categories.
●'''Class I''' – Conditions in which permanent pacing is definitely recommended, beneficial, and useful.
●'''Class II''' – Conditions in which permanent pacing may be reasonable, but there is conflicting evidence and/or divergence opinion.
●'''Class III''' – Conditions in which permanent pacing is not beneficial/useful and, in some cases, maybe harmful.
=== Class-I ===
* Symptomatic [[sinus bradycardia]] (usually with a heart rate below 40 beats per minute)
* Symptomatic chronotropic incompetence
* Patients with symptomatic [[sinus bradycardia]] as a consequence of guideline-directed management for which there is no alternative treatment and continued treatment is clinically necessary; a permanent pacemaker is recommended to improve symptoms.
* Complete heart block with or without sysmptoms
* Symptomatic second degree AV block, [[Mobitz type II]]
* Symptomatic second degree AV block, [[Mobitz type I]]
* Exercise induced second or third degree AV block in absence of [[myocardial ischemia]]
* Advanced second degree AV block (block of two or more consecutive P waves)
*Patients with the following neuromuscular diseases with evidence of second-degree or third-degree atrioventricular block require permanent pacemaker regardless of the symptoms.
**[[Myotonic dystrophy]] type 1
**[[Kearns-Sayre syndrome|Kearns-Sayre Syndrome]]
**[[Erb's dystrophy]] (limb-girdle)
**peroneal muscular atrophy
*Patients with permanent [[atrial fibrillation]] and symptomatic bradycardia.
*Patients with alternating bundle branch block
*Patients with postoperative [[sinus node dysfunction]] or [[atrioventricular block]] associated with persistent symptoms that do not resolve after isolated coronary artery bypass surgery
=== Class-II ===
* Asymptomatic [[Mobitz II|Mobitz II second degree AV]] block with a narrow QRS interval
* First degree AV block with hemodynamic compromise because of effective AV dissociation secondary to a very long PR interval.
*Patients with infiltrative cardiomyopathies, such as cardiac [[sarcoidosis]] or [[amyloidosis]], and second-degree Mobitz type II atrioventricular block, high-grade atrioventricular block, or [[Third-degree block|third-degree atrioventricular block]] with a life expectancy of greater than one years.
*Patients with marked first-degree or second-degree [[Mobitz type 1 atrioventricular block|Mobitz type 1]] AV block with symptoms that are attributable to the atrioventricular block.
*Patients with [[Anderson-Fabry disease|Anderson-Fabry]] disease and QRS prolongation more significant than 110 ms with a meaning life expectancy greater than one year
*Bifascicular or trifascicular block associated with syncope that can be attributed to transient complete heart block
*[[Congenital heart block]]
=== Class-III ===
*[[Sinus bradycardia]] without significant symptoms
* Sinoatrial block or sinus arrest without significant symptoms.
*[[Syncope]] of undetermined etiology
* Asymptomatic prolonged RR intervals with atrial fibrillation
* Asymptomatic bradycardia during sleep
*[[Long QT syndrome]] or [[Torsade de pointes|torsades de pointes]] due to reversible causes
* Asymptomatic second degree Mobitz I AV block
* Reversible [[atrioventricular block]]
* A hyperactive cardioinhibitory response to [[carotid sinus stimulation]] in the absence of symptoms
*
<br />
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 13:16, 24 June 2021

Third degree AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Third degree AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Third degree AV block surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Third degree AV block surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Third degree AV block surgery

CDC on Third degree AV block surgery

Third degree AV block surgery in the news

Blogs on Third degree AV block surgery

Directions to Hospitals Treating Third degree AV block

Risk calculators and risk factors for Third degree AV block surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Raviteja Guddeti, M.B.B.S. [3] Soroush Seifirad, M.D.[4] Qasim Khurshid, M.B.B.S [5]

Overview

Cardiac pacemakers are effective treatments for a variety of cardiac conduction abnormalities and can reestablish adequate circulation by generating appropriate heart rate and cardiac response. Two main factors guide the majority of decisions regarding permanent pacemaker insertion. First is the association of symptoms with arrhythmia, and second is the potential for progression of the rhythm disturbance.


Surgury

Recommendation for placement of permanent pacing

Recommendations for permanent pacing for chronic management of Bradycardia Attributable to Atrioventricular Block
(Class I, Level of Evidence B):

Permanent pacing is recommended in patients with acquired second degree mobitz type2 atrioventricular block, high grade atrioventricular block, third degree atrioventricular block, regardless of symptoms that are not related to reversible causes
permanent pacing with additional defibrillator capacity is needed in patients with neuromuscular disease associated conduction disorder such as myotonic dystrophy type1 or kearn sayre syndrome and presence of second degree atrioventricular block, third degree atioventricular block, HV interval of 70 ms or greater, regardless of symptoms if life expectancy>1 year

( Class I, Level of Evidence C) :

Permanent pacing is recommended in patients with permanent atrial fibrillation and symptomatic bradycardia
❑ In patients with symptomatic atrioventricular block associated with necessary medications which there is not alternative treatment, permanent pacing is needed

(Class IIa, Level of Evidence B)

❑ In patients with cardiac sarcoidosis and amyloidosis and evidence of mobitz type 2 atrioventricular block, high grade atrioventricular block, third degree atrioventricular block , permanent pacing with additional defibrillator capacity is reasonable if life expectancy>1 year
❑ In patients with lamin A/C mutation such as limb girdle, emery driefuss muscular dystrophies with PR interval>240 ms and LBBB, permanent pacing with additional defibrillator capacity is reasonable if life expectancy >1 year

(Class IIa, Level of Evidence C)

❑ In patients with symptomatic first degree atrioventricular block or motitz tyoe 1 atrioventricular block, permanent pacing is recommended

(Class IIb, Level of Evidence C)

Permanent pacing with additional defibrillator capacity is recommended in patients with neuromuscular disease including myotonic dystrophy type1 with PR interval >240ms , QRS duration >120 ms, fascicular block if life expectancy>1 year

The above table adopted from 2018 AHA/ACC/HRS Guideline




Management of bradycardia or pauses attributable to chronic atrioventricular block algorithm

 
 
 
Atrioventricular block
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complete heart block (aquired)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Permanent pacing (class1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider risk for ventricular arrhythmia (class1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardiac resynchronization therapy
  • Is LVEF<35%?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO
 
Yes
  • Medical therapy
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    N0
  • Permanent atrial fibrillation
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    NO
  • Dual chamber pacing (class1)
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    LVEF>50%
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    NO
  • Is predicted pacing <40%
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    NO
     
    Yes
  • Righr ventricular pacing (class2a)
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    His bundle pacing (class2b)
     
     
     
     


    The above algorithm adopted from 2018 AHA/ACC/HRS Guideline







    Recommendations for temporary pacing for bradycardia associated atrioventricular block
    Medical therapy (Class IIa, Level of Evidence B):

    ❑ In patients with symptomatic bradycardia associated second or third degree atrioventricular block, refractory to medications, temporary transvenous pacing is recommended to increase heart rate and improve symptoms

    Surgery

    A permanent pacemaker insertion is a minimally invasive procedure. The procedure is typically performed in a cardiac catheterization lab or an operating room. Transvenous access to the heart chambers under local anesthesia is the preferred technique, most commonly via the subclavian vein, the cephalic vein, or the internal jugular vein or the femoral vein.The pacing generator is most commonly placed subcutaneously in the pre-pectoral region. Placement of pacemaker leads, surgically via thoracotomy, is rarely used these days.

    Types of permanent pacemaker systems

    All cardiac pacemakers consist of two components: a pulse generator that provides the electrical impulse for myocardial stimulation; and one or more electrodes that deliver the electrical impulse to the myocardium. The original cardiac pacing system was used to place surgically in the abdomen. Over time, pacemaker systems evolved to predominantly placing the pulse generator in the infraclavicular region of the chest with transvenous-placed endocardial leads. Transvenous leads have potential long-term complications, including venous thrombosis, infection, and lead malfunction. Leadless cardiac pacing systems are currently in development and offer the promise of long-term pacing capability without lead-associated complications.

    Transvenous systems

    The majority of cardiac pacing systems use transvenous electrodes to transmit pacing impulses from the generator to the myocardium. Transvenous leads are usually placed percutaneously or with a cephalic cutdown, without the need for intrathoracic surgery. Long term complications of transvenous electrodes include infection,venous thrombosis, lead malfunction, and tricuspid valve injury.

    Epicardial systems

    Epicardial cardiac pacemaker systems utilize a pulse generator with leads attached surgically directly to the epicardial surface of the heart. These systems are occasionally used in patients with vascular access problems and have been replaced by transvenous systems.

    Leadless systems

    In response to the limitations of existing pacings systems, leadless systems are developed. Leadless systems consist of a self-contained system that includes both the pulse generator and the electrode within a single unit that is placed into the right ventricle via a transvenous approach. Leadless cardiac pacing system was approved in April 2016 in the United States[1]

    References

    1. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm494390.htm

    Template:WikiDoc Sources